We previously showed that liver-derived XOR stimulated the proliferation and dedifferentiation of in vitro human VSMCs and in vivo neointima formation composed of proliferative SMCs in diet-induced NAFLD/NASH model mice, both of which were attenuated by the treatment with topiroxostat [13]. The gene discussed is XDH; the disease is metabolic dysfunction-associated steatotic liver disease.